Contact us

16 Results:

Sort By:

Late-onset sepsis reduced in premature infants fed Prolacta’s 100% human milk-based fortifiers as part of an exclusive human milk diet

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis

Prolacta Bioscience reassures hospitals of the safety of its human milk-based nutritional products during the coronavirus pandemic

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Pasteurization Quality & Safety

New Analysis Published in the Journal Breastfeeding Medicine Finds Additional Clinically Significant Benefits From an Exclusive Human Milk Diet in the NICU

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Cost Savings / Cost Effectiveness Necrotizing Entercolitis (NEC) Product Total Parenteral Nutrition (TPN) Use

Length of stay in the NICU and association with breastfeeding rates | LATCH

Type: Blog

Topic(s): Clinical Studies Length of hospital stay

Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition

Type: Prolacta in the News

Topic(s): Clinical Studies Company Single Ventricle Congenital Heart Defects (SVP )

Prolacta Bioscience Initiates Clinical Trial to Evaluate the Effect of a Specially Fortified Exclusive Human Milk Diet to Improve Growth in Infants Born with Single Ventricle Congenital Heart Defect

Type: Press Releases

Topic(s): Clinical Studies Single Ventricle Congenital Heart Defects (SVP )

New Journal of Perinatology Study Associates an Exclusive Human Milk Diet With Lower Total Hospital Costs for Very Low Birth Weight Infants

Type: Press Releases

Topic(s): Clinical Studies Cost Savings / Cost Effectiveness

Benefits of an Exclusive Human Milk Diet Extend Beyond Reduction of NEC, Finds New Study Published in the Journal Breastfeeding Medicine

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)

Texas Children's Hospital Breast Milk Donor Program in the News!

Type: Prolacta in the News

Topic(s): Advocacy Clinical Studies Company

Not finding the reference you’re looking for?

Email us at info@prolacta.com